Mitesh

Update 29/01/26 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Estradot® 50micrograms/24hours patches (SSP079), Estradot® 75micrograms/24hours patches (SSP080), Estradot® 100micrograms/24hours patches (SSP081) and Estradot® 25micrograms/24hours patches (SSP082). All four SSPs were due to expire on 30 January 2026. The end date for all [...]

The post SSPs for Estradot® patches (SSP079, SSP080, SSP081, SSP082) further extended appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) Drug alert number: EL (24)A/63 Date issued: 19 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Vyvgart 1000 mg solution for injection (Argenx BV) DMRC reference number: DMRC-34131563 Company name:Argenx [...]

The post MHRA Class 4 Medicines Defect Information: Vyvgart 1000 mg solution for injection (Argenx BV) appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 5 December 2024) has been published and includes articles on: Letters and medicine recalls sent to healthcare professionals in November 2024 To see th...

Update 24/10/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Cefalexin 125mg/5ml oral suspension sugar free (SSP077) and Cefalexin 250mg/5ml oral suspension sugar free (SSP078). Both SSPs were due to expire on 24 October 2025. The end date for the two Cefalexin oral [...]

The post SSPs for Cefalexin oral suspensions sugar free further extended appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has via its Central Alerting System (CAS) published a letter on 3 December 2024 advising that due to increasing flu levels in the community, Prescribers working in primary care may now prescribe, and community pharmacists may now supply antiviral medicines (oseltamivir and zanamivir) for the prophylaxis and [...]

The post DHSC permits use of antiviral medicines against influenza appeared first on Community Pharmacy England.